Skip to content
Global markets · Independent coverage Follow a hub and receive new coverage by email.

NASDAQ:GNPX

Genprex (NASDAQ:GNPX) Stock Skyrockets 40% on Lung Cancer Gene Therapy Breakthrough

Genprex shares have been extremely volatile. After surging over 30% during regular hours on Oct 14, 2025, to about $0.25, the stock jumped another 41% in after-hours trading to roughly $0.36 on the cancer…

11 min read
BiotechnologyHealth NewsNASDAQ:GNPX

Company hubNASDAQ:GNPX

Genprex (NASDAQ:GNPX) (GNPX) Stock News & Analysis

Follow the latest Genprex (NASDAQ:GNPX) (GNPX) company news, earnings coverage and investor analysis from TechStock².

Save this hub to your TS2 Signalbook account.
Latest update
Articles in this hub
1
Last 30 days
0

What investors are watching

  • Earnings, guidance and financial performance
  • Valuation, trading activity and market sentiment
  • Strategy, catalysts and company-specific risks

All coverage

NASDAQ:GNPX

1 articles